Publications

• Kim, G; Sayer, G; Ransom, J; Keebler, M; Katz, J; Kilic, A; Lindenfeld, J; Egnaczyk, G; Shah, P; Brieke, A; Walenga, J; Crandall, D; Farrar, DJ; Sundareswaran, K; Uriel, N Association of Angiopoetin-2 and TNF-a With Bleeding During Left Ventricular Assist Device Support: Analysis from the PREVENT Biorepository. ASAIO Journal (American Society for Artificial Internal Organs : 1992) ;
• O'Hara, A; Pozin, J; Darki, A; Siddiqui, F; Hoppensteadt, D; Walenga, J; Fareed, J; Kantarcioglu, B Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis ; 29
• Jeske, W; Ransom, J; Katz, JN; Kilic, A; Lindenfeld, J; Egnaczyk, G; Shah, P; Brieke, A; Uriel, N; Crandall, D; Farrar, DJ; Walenga, JM Enhanced Thrombin Formation in Patients with Ventricular Assist Devices Experiencing Bleeding: Insights from the Multicenter PREVENT Study. ASAIO Journal (American Society for Artificial Internal Organs : 1992) ;
• Kantarcioglu, B; Darki, A; Siddiqui, F; Krupa, E; Vural, M; Kacmaz, M; Hoppensteadt, D; Iqbal, O; Jeske, W; Walenga, J; Adiguzel, C; Fareed, J Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis ; 28
• Jaradeh, M; Curran, B; Poulikidis, K; Rodrigues, A; Jeske, W; Abdelsattar, ZM; Lubawski, J; Walenga, J; Vigneswaran, WT Inflammatory cytokines in robot-assisted thoracic surgery versus video-assisted thoracic surgery. Journal of thoracic disease ; 14 6
• Thacker, BE; Thorne, KJ; Cartwright, C; Park, J; Glass, K; Chea, A; Kellman, BP; Lewis, NE; Wang, Z; Di Nardo, A; Sharfstein, ST; Jeske, W; Walenga, J; Hogwood, J; Gray, E; Mulloy, B; Esko, JD; Glass, CA Multiplex genome editing of mammalian cells for producing recombinant heparin. Metabolic engineering ; 70
• Kantarcioglu, B; Iqbal, O; Walenga, JM; Lewis, B; Lewis, J; Carter, CA; Singh, M; Lievano, F; Tafur, A; Ramacciotti, E; Gerotziafas, GT; Jeske, W; Fareed, J An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis ; 27
• Newman, Joshua; Brailovsky, Yevgeniy; Allen, Sorcha; Masic, Dalila; Bontekoe, Emily; Walenga, Jeanine; Fareed, Jawed; Darki, Amir ANGIOPOIETIN-2 IS A POWERFUL PREDICTOR OF SEVERITY OF ILLNESS, RIGHT VENTRICULAR DYSFUNCTION AND IN HOSPITAL MORTALITY IN ACUTE PULMONARY EMBOLISM. Journal of the American College of Cardiology (JACC) ; 77 18
• Newman, J; Brailovsky, Y; Allen, S; Bontekoe, E; Masic, D; Walenga, J; Fareed, J; Darki, A Angiopoietin-2 correlates with pulmonary embolism severity, right ventricular dysfunction, and intensive care unit admission. Vascular medicine (London, England) ;
• Walenga, JM; Torres, TA; Jeske, WP; Schwartz, J; Escalante, V; Newman, JD; Bakhos, M Protein C Pathway, Inflammation, and Pump Thrombosis in Patients With Left Ventricular Assist Devices. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis ; 26Walenga, JM Heparin: Much more than anti-IIa/anti-Xa. Journal de medecine vasculaire ; 45 3
• Jeske, W; Kouta, A; Farooqui, A; Siddiqui, F; Rangnekar, V; Niverthi, M; Laddu, R; Hoppensteadt, D; Iqbal, O; Walenga, J; Fareed, J Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels. Frontiers in medicine ; 5Ramacciotti, E; Agati, LB; Aguiar, VCR; Wolosker, N; Guerra, JC; de Almeida, RP; Alves, JC; Lopes, RD; Wakefield, TW; Comerota, AJ; Walenga, J; Fareed, J Zika and Chikungunya Virus and Risk for Venous Thromboembolism. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2019-12-02 00:00:00.0; 25
• McClane, N; Jeske, W; Walenga, JM; Escalante, V; Hoppensteadt, D; Schwartz, J; Bakhos, M Identification of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients Implanted With a Continuous-Flow Left Ventricular Assist Device. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis ; 24 6
• Prechel, M; Hudec, S; Lowden, E; Escalante, V; Emanuele, N; Emanuele, M; Walenga, JM Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis ;
• Ramacciotti, E; Castelli, V; Walenga, J; Fareed, J Medical management of stable peripheral artery disease: the COMPASS trial. Perspectives from a vascular standpoint. International angiology : a journal of the International Union of Angiology ; 37 4
• Quinn, Kristina; Doukas, Demetrios; Balasubramanian, Neelam; Torres, Tania; Walenga, Jeanine; Coglianese, Erin 317 - Clinical and Hemostatic Characteristics of Patients With Ventricular Assist Device Thrombosis. Journal of cardiac failure ; 22 5
• Harenberg, J; Du, S; Wehling, M; Zolfaghari, S; Weiss, C; Krämer, R; Walenga, J Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study. Clinical chemistry and laboratory medicine ; 54 2
• Walenga, Jeanine M; Prechel, Margaret; Jeske, Walter P; Bakhos, Mamdouh Unfractionated heparin compared with low-molecular-weight heparin as related to heparin-induced thrombocytopenia. Current opinion in pulmonary medicine ; 11